AJP - Heart AJP: Advances in Physiology Education
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 242: H573-H579, 1982;
0363-6135/82 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hilliker, K. S.
Right arrow Articles by Roth, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hilliker, K. S.
Right arrow Articles by Roth, R. A.

AJP - Heart and Circulatory Physiology, Vol 242, Issue 4 573-H579, Copyright © 1982 by American Physiological Society

ARTICLES

Pneumotoxicity and thrombocytopenia after single injection of monocrotaline

K. S. Hilliker, T. G. Bell and R. A. Roth

Adult Sprague-Dawley rats were treated once with 105 mg/kg monocrotaline (MCT) subcutaneously or an equivalent volume of isotonic saline and examined 2, 5, 10, and 14 days later. The earliest changes observed were in the platelet count, which was decreased in the MCT animals at 2, 5, and 10 days postinjection. Clearance of perfused 5-hydroxytryptamine, a function of pulmonary vascular endothelium, was unaltered in isolated lungs of treated rats until 5 days after dosing but decreased progressively thereafter in the MCT animals and was 24% less than controls by 14 days. The magnitude of this effect was dose related. Inflow perfusion pressure was elevated in perfused lungs of MCT-treated animals at day 14. Right heart hypertrophy, measured as an increase in the ratio of right ventricle to left ventricle plus septum weights, was not evident until 14 days after treatment. A larger dose of MCT (130 mg/kg) resulted in significant mortality, whereas a lower dose (60 mg/kg) did not result in right ventricular hypertrophy 2 wk after treatment. The treatment regimen described has advantages over administration of MCT by ingestion and may prove suitable for investigations of the mechanism by which MCT results in pulmonary hypertension.


This article has been cited by other articles:


Home page
 J. Appl. Physiol.Home page
E. Azoulay, S. Eddahibi, E. Marcos, M. Levame, A. Harf, B. Schlemmer, S. Adnot, and C. Delclaux
Granulocyte colony-stimulating factor enhances alpha-naphthylthiourea-induced pulmonary hypertension
J Appl Physiol, May 1, 2003; 94(5): 2027 - 2033.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
K. M. Ito, M. Sato, K. Ushijima, M. Nakai, and K. Ito
Alterations of endothelium and smooth muscle function in monocrotaline-induced pulmonary hypertensive arteries
Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1786 - H1795.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
H. C. Thomas, M. W. Lamé, D. Morin, D. W. Wilson, and H. J. Segall
Prolonged Cell-cycle Arrest Associated with Altered cdc2 Kinase in Monocrotaline Pyrrole-treated Pulmonary Artery Endothelial Cells
Am. J. Respir. Cell Mol. Biol., July 1, 1998; 19(1): 129 - 142.
[Abstract] [Full Text]

Home page
 J. Appl. Physiol.Home page
G. L. Colice, N. Hill, Y.-J. Lee, H. Du, J. Klinger, J. C. Leiter, and L.-C. Ou
Exaggerated pulmonary hypertension with monocrotaline in rats susceptible to chronic mountain sickness
J Appl Physiol, July 1, 1997; 83(1): 25 - 31.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
Y. L. Lai and K.-R. Zhou
Eglin-c prevents monocrotaline-induced ventilatory dysfunction
J Appl Physiol, January 1, 1997; 82(1): 324 - 328.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online